The ethics committee of the University of Leipzig approved all experiments with human materials, and informed consent was obtained from all participants.
The survey instrument materials (survey, informed consent document, and letters of support from the Gates Foundation, WHO, and GHWA) were then e-mailed to the dean or an appropriate respondent identified by the dean.
The purpose of the survey was described in a preamble (Supplemental Material S1), and informed consent was given by moving from the preamble to the survey itself.
Prior to the use of all of the clinical materials for investigation, informed consent from patients and approval from the Institute Research Ethics Committee were obtained.
Prior to the use of these clinical materials for investigation, informed consent from patients and approval from the Institute Research Ethics Committee were obtained.
For human material, informed written consent was received from participants prior to inclusion in the study under ethics committee number MREC 01/4/061.
All biological material was sampled upon informed consent.
The University of Florida Health Science Center Institutional Review Board (IRB-01) reviewed and approved all study materials including the study protocol, informed consent document, recruitment materials, and assessment instruments.
The Institutional Review Board (IRB) of the University of the Sciences (IRB# 288168 10) reviewed and approved all study materials including the study protocol, informed consent document, recruitment materials, and assessment instruments and approved the human research participant protection procedures for this trial.
Researchers say that the controversy prompted some trials involving infants to halt work while organizers reviewed and revised materials used to acquire informed consent.
